Medicare Spending and Financing: The Same Dollars Can Tell Very Different Stories

Medicare spending, trust funds and fraud statistics only make sense together when they cover the same program, period and kind of money. Payroll taxes, premiums and federal contributions finance the program. A claim submitted, a payment made and a rebate returned describe different points in its business. For a healthcare billing, plan finance or rebate employee, the question is which representation changed the government’s payment.

The 2026 Medicare Trustees report puts calendar-year 2025 expenditures at $1,210.1 billion. That is the program’s cash-account spending, including administration. We want the connection between the false representation and the money it changed.

Where Medicare Trust Funds Get Their Money

Payroll taxes, federal contributions, beneficiary premiums and state payments finance Medicare’s trust accounts. Hospital Insurance finances Part A. Supplementary Medical Insurance contains the separate Part B and Part D accounts. Their revenues and obligations differ, and the money cannot simply move between them to cover a shortfall.

Part A helps pay for inpatient hospital care, skilled nursing care, hospice and certain home health services. Part B covers physician, outpatient hospital and other services. Part D subsidizes prescription drug coverage. In calendar 2025, the Trustees reported expenditures of $444.2 billion for Part A, $584.3 billion for Part B and $181.5 billion for Part D.

The financing split matters just as much. Payroll taxes supplied $403.2 billion to Hospital Insurance that year. Federal contributions across Medicare totaled $572.9 billion, concentrated in Parts B and D. Beneficiary premiums also support the accounts, and states contribute to Part D. Calling all Medicare spending payroll-tax money misses much of what pays the bills.

Medicare Advantage changes the payment route. Contractors pay provider claims in Original Medicare. Medicare Advantage plans receive advance monthly payments to provide covered benefits. Those Part C payments come from the Part A and Part B accounts. The Trustees’ $530.9 billion in Part C benefit payments for 2025 is already inside the A/B totals. Adding it again would count the same money twice.

Enrollment has the same overlap problem. A person can have Part A, Part B and Part D coverage. The Trustees report total Medicare enrollment separately from enrollment in each part, and their private-plan category includes more than Medicare Advantage.

Medicare Trust-Fund Spending Versus Accrual Expenses

Trust-fund spending and accrual expenses differ in when the money counts. Cash accounting follows payment. Incurred spending follows the service. Accrual financial statements recognize expenses when incurred, whether or not cash has moved.

The Trustees’ cash series assigns a payment to the year it was made, including payments for earlier services. Their incurred series assigns spending to the year the services occurred. The distinction matters to anyone comparing a provider’s service records with its remittances: treatment and payment need not fall in the same reporting year.

The National Health Expenditure accounts use an incurred spending approach. The Centers for Medicare & Medicaid Services’ historical national spending figures put Medicare at $1,118.0 billion for calendar 2024. The 2026 Trustees report gives cash expenditures of $1,122.0 billion for that same year.

The agency’s fiscal-year 2025 financial report answers another question. Its consolidated statement of net cost covers the year ended September 30, 2025. It presents Hospital Insurance and Supplementary Medical Insurance separately, deducting earned revenues from gross costs. Net cost does not subtract every tax or appropriation that finances Medicare.

The Trustees revise historical figures as later information arrives, so the report’s year belongs with the spending year.

Pandemic accelerated and advance payments show the timing difference: the Trustees’ cash series includes $100.5 billion in net advances in 2020, followed by net repayments of $47.9 billion in 2021, $51.5 billion in 2022 and $0.8 billion in 2023. Those movements put cash ahead of the ordinary claims-payment schedule and then brought it back.

Part D Spending Net of Rebates

Part D spending net of rebates depends on which payment is being measured and when the rebate enters the account. The pharmacy transaction, the sponsor’s reimbursement and the Part D trust account have different boundaries.

For calendar 2024, the Medicare Payment Advisory Commission’s July 2026 Data Book reports $288.9 billion in gross pharmacy spending. That includes beneficiary cost sharing and plan and other-payer payments at the pharmacy, before postsale concessions. For the same year, the 2026 Trustees report gives $156.9 billion in incurred Part D reimbursements and $146.1 billion in Part D cash expenditures.

Same year. Very different measures.

Incurred reimbursements include premiums and federal subsidies. Cash expenditure reflects when payments and reconciliation adjustments reach the account. The Trustees also include estimated premiums paid directly to plans, so their Part D presentation reaches beyond Treasury transfers.

Plan sponsors and pharmacy benefit managers negotiate manufacturer rebates and other price concessions after the pharmacy sale. The Centers for Medicare & Medicaid Services calls those concessions direct and indirect remuneration. Medicare retains a portion to offset reinsurance subsidies. The price on a drug event is therefore only part of the federal payment story.

The commission reports that direct and indirect remuneration fell from about $92 billion in 2023 to about $79 billion in 2024. It attributes the decline to a requirement to reflect pharmacy direct and indirect remuneration at the point of sale beginning in 2024. A concession moved into the pharmacy price will no longer appear in the same later-payment bucket.

The Centers for Medicare & Medicaid Services’ instructions for certifying the 2025 data, issued in August 2026, make the connection to payment explicit. Sponsors certify that prescription drug event data, summary rebate data and other information used to determine allowable reinsurance and risk-sharing costs are accurate, complete and truthful. An executive signs the attestation. These are representations used to obtain federal reimbursement.

When a Rebate Becomes a Service Fee on Paper

Rite Aid and Elixir Insurance Company agreed in July 2024 to pay $101 million to resolve allegations of falsely reporting rebates. The Department of Justice alleged that retained manufacturer rebates appeared as bona fide service fees on Elixir’s reports to CMS, although the fees did not meet that definition. We call that an expensive way to admit nothing.

The whistleblower’s complaint alleged that the supporting valuation paperwork itself had been manufactured:

The allegation puts the accounting choice inside the business: who classified the money, what service supposedly earned it and what supported that explanation. We follow those decisions through the rebate reports, certifications and payment records. The useful comparison is between the transaction and the representation that changed reimbursement.

What Are the Most Common Causes of Improper Medicare Payments?

Missing or insufficient documentation, records that fail to support payment, and failures to meet payment requirements are central causes in the Centers for Medicare & Medicaid Services’ fiscal-year 2025 improper-payment account. Its estimates include overpayments, underpayments and payments whose correctness reviewers could not determine.

The agency estimated improper payments of $28.83 billion, or 6.55%, for fee-for-service Medicare. Part C accounted for $23.67 billion, or 6.09%, and Part D for $4.23 billion, or 4.00%. Each estimate measures compliance with that program’s payment requirements.

In Part C, most improper payments involved documentation that failed to support the diagnoses submitted for payment. Risk adjustment uses diagnosis data to set a plan’s monthly payment, drawing on Parts A and B. An insider who knows how unsupported diagnoses reached the payment data can connect the coding decisions to the money.

The Department of Health and Human Services’ fiscal-year 2025 financial report gives the underlying periods: claims submitted from July 2023 through June 2024 for fee-for-service Medicare, and 2023 payments for Parts C and D.

What a Specific Fraud Estimate Can Tell Us

Medicare Home Health Fraud: How Much, Where, and Who?, a National Bureau of Economic Research working paper published in May 2026, illustrates a more specific approach. The study used claims and federal strike-force prosecution records to model which home health agencies would have been prosecuted in districts without a strike force. Its definition classified an agency as fraudulent if a federal strike force prosecuted it.

The finding concerns spending billed by agencies classified under that method, in that service and year. Its specificity gives the estimate meaning.

Is Stopped or Seized Money the Same as Money Returned to Medicare?

No. Prevention stops a payment, suspension withholds it, and recovery brings money back. Seizing an asset and assigning an amount to Medicare are also different from completing the transfer into its account. A settlement establishes an obligation to pay. A receipt establishes payment.

The distinction has practical consequences inside a provider’s finance department. The Department of Health and Human Services’ Office of Inspector General, in its 2025 review of electronic funds transfer fraud, described people impersonating hospital providers and submitting fraudulent authorization requests to divert Medicare and Medicaid payments. The destination bank account can be the point of the scheme. Understanding the claim alone would miss where the payment went.

The Centers for Medicare & Medicaid Services reported $41.9 billion in Medicare program-integrity savings for fiscal 2025. Its May 2026 announcement attributed 68% to cost avoidance, including revocations and automated denials. Most of those savings came from keeping money from leaving.

The Health Care Fraud and Abuse Control Program’s fiscal-year 2023 report separately identifies Medicare trust-fund transfers, Medicaid amounts and payments to whistleblowers. Its return-on-investment calculation compares specified returns with enforcement funding.

What the Medicare Trust-Fund Projection Means

The Hospital Insurance reserve-depletion projection describes the relationship between Part A financing and scheduled costs.

Under the 2026 Trustees’ intermediate assumptions, Hospital Insurance reserves run out in the second quarter of 2033. Continuing income would cover 89% of scheduled benefits in that year. Parts B and D have different financing: premiums and general-fund contributions reset to cover the following year’s estimated expenditures.

That split reflects Medicare’s development. The program began with hospital and medical insurance, and prescription drug coverage started in 2006. A financing description built around the hospital payroll tax alone leaves out the later drug benefit and the general-revenue financing already central to medical insurance.

The projections change with spending experience, assumptions and law. The 2024 Trustees report projected Hospital Insurance depletion in 2036. As the agency’s fiscal-year 2025 financial report explains, the next Trustees report moved it earlier. The year attached to a projection is part of its meaning.

Medicare Fraud Denominator and Total Spending

Comparing Medicare fraud with total spending starts with the same payment population on both sides. The program component, service or payment period, report edition, accounting basis and payment stage all affect what the comparison says. Part C inclusion and Part D rebate treatment matter before any percentage is calculated.

For an insider, the more useful question is smaller and sharper. Which claim, diagnosis, rebate classification or bank instruction changed the payment? Who knew what the underlying records showed? The national accounts explain the scale of the program. The company’s own records connect its decisions to the money.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know Why the Numbers Changed

If you work in health care finance, plan payments or rebate reporting and know why the government’s figures differ from the business’s own records, speak with our whistleblower experts about that discrepancy. We work beside you to turn what you know about those accounting decisions into a Medicare whistleblower case. We bring in Medicare fraud whistleblower lawyers who understand claims and reimbursement, and stay with you through the case.